Ganesh Benzoplast Limited has informed the Exchange about statement of deviation(s) or variation(s) under Reg. 32
GANESHBE · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Ganesh Benzoplast Limited has filed its quarterly statement of deviation for the quarter ended March 31, 2026, covering funds raised via a preferential issue of equity shares on March 1, 2024, totalling Rs. 32.40 crores. The company has explicitly confirmed that there is NO deviation or variation in the use of proceeds from the preferential issue. All funds were deployed as per the stated objects: capital expenditure and working capital requirements, business expansion directly or through subsidiaries/joint ventures/associates, and general corporate purposes. No changes to original objects were approved, and no comments were raised by the Audit Committee or auditors.
No red flags here — the company deployed the full Rs. 32.40 crore preferential issue proceeds as planned with no deviations reported. This is a clean compliance filing and generally neutral-to-slightly-positive for shareholder confidence.